Bystander elimination of antigen loss variants in established tumors

Michael T Spiotto1, Donald A Rowley, Hans Schreiber

  • 1Department of Pathology and The Committee on Immunology, The University of Chicago, Chicago, Illinois 60637, USA. mspiotto@midway.uchicago.edu

Nature Medicine
|February 26, 2004
PubMed

Insights

Cytotoxic T lymphocytes (CTLs) can eliminate cancer antigen loss variants (ALVs) indirectly. Targeting tumor stroma is crucial to prevent cancer immune escape and improve therapy efficacy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Cancer cells express antigens recognized by cytotoxic T lymphocytes (CTLs).
  • Genetic instability in cancer leads to antigen loss variants (ALVs) that evade CTL destruction.
  • Effective CTL responses are critical for controlling tumor progression.

Purpose of the Study:

  • To investigate the mechanisms by which CTLs eliminate antigen loss variants (ALVs).
  • To determine the role of tumor antigen expression levels and tumor stroma in ALV elimination.
  • To explore strategies for preventing cancer immune escape.

Main Methods:

  • Utilized a model system to study cancer cell-tumor stroma interactions.
  • Manipulated antigen expression levels on parental cancer cells.
  • Assessed CTL-mediated elimination of both parental cancer cells and ALVs.
  • Analyzed the role of stromal cells and MHC molecule expression in antigen cross-presentation.

Main Results:

  • Sufficient parental tumor antigen expression enabled indirect elimination of ALVs via cross-presentation by the tumor stroma.
  • Low antigen expression led to CTLs eradicating parental cells but ALVs escaping and causing host death.
  • High antigen expression resulted in CTLs eliminating both parental cells and ALVs.
  • Bystander elimination of ALVs required MHC-expressing stromal cells and occurred during stromal destruction.

Conclusions:

  • Indirect elimination of ALVs by CTLs is possible through cross-presentation by tumor stroma.
  • Tumor antigen levels significantly impact the efficacy of CTLs against ALVs.
  • Targeting the tumor stroma is a potential strategy to overcome cancer immune escape mediated by ALVs.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Vaccinations01:51

Vaccinations

Overview
52.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K